Antibiotic-resistant bacteria are increasingly the source of deadly infections. Scientists have now modified an approved cancer drug to develop an active agent against multidrug-resistant pathogens.
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024Metronidazole for bacterial infection
February 1, 2023